CD274 and neoplasm: In particular, we wanted to identify genes that are altered during a productive anti-tumor immune response that may enhance T cell infiltration and efficacy of PD-1/PD-L1 blockade, with the ultimate goal of discovering novel therapeutic strategies to overcome resistance to PD-1/PD-L1 blockade.